Evidence map›Paper›PMID 23945716›Full record

Trial reportThe American journal of clinical nutrition2013

Effects of sea buckthorn and bilberry on serum metabolites differ according to baseline metabolic profiles in overweight women: a randomized crossover trial.

Petra S Larmo, Antti J Kangas, Pasi Soininen, Henna-Maria Lehtonen, Jukka-Pekka Suomela, Baoru Yang, Jorma Viikari, Mika Ala-Korpela, Heikki P Kallio

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01860547 (The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01860547 nacompletednot on this map

The Effect of the Bioactives of Sea Buckthorn and Bilberry on the Risk of Metabolic Diseases

TypeinterventionalSponsorUniversity of TurkuRan2008 to 2009Enrolled110ConditionsType 2 Diabetes, AtherosclerosisArmsBilberries, Sea buckthorn berry, Sea buckthorn phenolic extract, Sea buckthorn oil
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Research progress of sea buckthorn (Frontiers in cardiovascular medicine · 2024
    Review
  3. Phytochemistry and pharmacology of sea buckthorn (Phytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Petra S LarmoDepartments of Biochemistry and Food Chemistry and Medicine, University of Turku, Turku, Finland; Aromtech Ltd, Tornio, Finland.
Antti J Kangas
Pasi Soininen
Henna-Maria Lehtonen
Jukka-Pekka Suomela
Baoru Yang
Jorma Viikari
Mika Ala-Korpela
Heikki P Kallio

Funding

Medical Research Council MC_UU_12013/1
6 · The paper itself

Abstract

backgroundBerries are associated with health benefits. Little is known about the effect of baseline metabolome on the overall metabolic responses to berry intake.

objectiveWe studied the effects of berries on serum metabolome.

designEighty overweight women completed this randomized crossover study. During the interventions of 30 d, subjects consumed dried sea buckthorn berries (SBs), sea buckthorn oil (SBo), sea buckthorn phenolics ethanol extract mixed with maltodextrin (SBe+MD) (1:1), or frozen bilberries. Metabolic profiles were quantified from serum samples by using (1)H nuclear magnetic resonance spectroscopy.

resultsAll interventions induced a significant (P < 0.001-0.003) effect on the overall metabolic profiles. The effect was observed both in participants who had a metabolic profile that reflected higher cardiometabolic risk at baseline (group B: P = 0.001-0.008) and in participants who had a lower-risk profile (group A: P < 0.001-0.009). Although most of the changes in individual metabolites were not statistically significant after correction for multiplicity, clear trends were observed. SB-induced effects were mainly on serum triglycerides and very-low-density lipoprotein (VLDL) and its subclasses, which decreased in metabolic group B. SBo induced a decreasing trend in serum total, intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL) cholesterol and subfractions of IDL and LDL in group B. During the SBe+MD treatment, VLDL fractions and serum triglycerides increased. Bilberries caused beneficial changes in serum lipids and lipoproteins in group B, whereas the opposite was true in group A.

conclusionBerry intake has overall metabolic effects, which depend on the cardiometabolic risk profile at baseline. This trial was registered at clinicaltrials.gov as NCT01860547.

Indexed as

HippophaeVaccinium myrtillusAdultBiomarkersCardiovascular DiseasesCarrier ProteinsCholesterolCholesterol, LDLCross-Over StudiesDietDietary SupplementsFemaleFood, PreservedFruitHumansLipoproteinsBiomarkersCarrier ProteinsCholesterolCholesterol, LDLLipoproteinsLipoproteins, IDLLipoproteins, VLDLPlant ExtractsPlant OilsTriglyceridesZdhhc23 protein, rat

Identifiers

PMID23945716
PMCPMC3778864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.